RDY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Dr Reddy's Laboratories Ltd (RDY) is not a strong buy for a beginner, long-term investor at this moment. The technical indicators are bearish, the financial performance is declining, and there are no significant positive catalysts or trading signals to justify an immediate purchase. Holding off for now is recommended.
The technical indicators show a bearish trend. The MACD histogram is negative and contracting, the RSI is neutral at 43.175, and the moving averages indicate a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 13.874, with key support at 13.518 and resistance at 14.229.
NULL identified. There is no recent news, no significant hedge fund or insider activity, and no recent congress trading data.
The company's financial performance in Q3 2026 shows a YoY decline in revenue (-1.02%), net income (-18.84%), EPS (-20.00%), and gross margin (-8.61%). Additionally, the stock has a higher chance of a negative return in the next week (-1.12%).
In Q3 2026, the company's revenue dropped to $979.8M (-1.02% YoY), net income dropped to $135.8M (-18.84% YoY), EPS dropped to $0.16 (-20.00% YoY), and gross margin dropped to 53.63% (-8.61% YoY). This indicates a weakening financial position.
No recent analyst rating or price target changes available.
